Search results

The Mrs Berta Kamprad Foundation is donating SEK 420 million to cancer research at Lund University. This is the largest donation to the university since its foundation in 1666. The donation is dedicated to translational cancer research, meaning applied cancer research in antibody and cell therapies with the aim of improving prognosis and quality of life for today's cancer patients.The administrati

https://www.lucc.lu.se/article/sek-420-million-cancer-research-lund-university - 2026-05-01

The Swedish Cancer Society awards Kristian Pietras the Cancer Researcher of the Year 2025 honour. He is a professor of molecular medicine at Lund University and is being recognised for his research on the tumour microenvironment, which has given us the key to understanding how cells in blood vessels and connective tissue interact with tumour cells. The motivation for the Cancer Foundation's ‘Cance

https://www.lucc.lu.se/article/kristian-pietras-named-cancer-researcher-year-2025 - 2026-05-01

A new research center CIRCE at Lund University have been granted long-term funding from Forte and VR at the end of 2025. It is led by LUCC researchers Lao Saal and Sophia Zackrisson in the area of Women’s Health and Disease. Obtaining such grant allows a systemic change in health care approach focusing on female health. It enables large-scale research on women’s cancers that bridges between discip

https://www.lucc.lu.se/article/centre-interdisciplinary-research-cancer-and-equity-women-launches - 2026-05-01

Thank you to everyone who made their way through the snowstorm and made it to Forum Cancer in connection with World Cancer Day at Forum Medicum in Lund. We had a very pleasant evening with Cristin Lind from EUPATI, who spoke about patient involvement in research.The award for Best Doctoral Thesis of the Year 2025 in the field of cancer at Lund University was presented to Ervin Ascic.Several patien

https://www.lucc.lu.se/article/forum-cancer-connection-world-cancer-day - 2026-05-01

LUCC is growing and currently 3 tenure track positions are available at our research environment. Three Assistant Professors in the field of Immunotherapy will be hired in the following months through the Lund University Programme for Global Excellence. An attractive start-up package is prepared for excellent international candidates who would like to start their long-term academic careers. The se

https://www.lucc.lu.se/article/three-tenure-track-positions-available-within-immunotherapy - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden’s most common forms of cancer. A research team at Lund University in Sweden has studied a protein that regu

https://www.lucc.lu.se/article/protein-linked-aggressive-skin-cancer - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. The first evidence was recently presented demonstrating how the immune system can be controlled by directly reprogramming connective tissue cells into immune cells. The discovery provides the opportunity to develop an entirely new strategy for targeted immunotherapy against cancer. Filipe Pereira, research team leader

https://www.lucc.lu.se/article/research-project-develop-innovative-strategy-cancer-therapy - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. In recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personalised treatment of lymph nodes in breast cancer patients. The latest results that have now been published in Clinical Cancer Research and BMC Cancer show that up

https://www.lucc.lu.se/article/fewer-lymph-node-operations-breast-cancer-patients-new-prediction-models - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. In a new national register study from Lund University in Sweden, researchers have studied the link between prostate cancer and infertility. The study, published in the British Medical Journal, includes over one million Swedish men. “Men who seek health care for infertility and assisted reproduction were shown to be at

https://www.lucc.lu.se/article/link-between-assisted-reproduction-and-risk-prostate-cancer - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Lund researchers Anna Sundlöv and Katarina Sjögreen-Gleisner have developed a method to personalise treatment using a newly approved radioactive cancer drug – by taking images of the drug’s dispersion inside the patient. Their article won the best publication of the year prize awarded by the journal EJNMMI Physics. 17

https://www.lucc.lu.se/article/researchers-lund-receive-prize-publication-year - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Triple negative breast cancer is an aggressive type of cancer representing approximately nine percent of all breast cancer cases in Sweden. It is more common among younger women, has a high heredity factor and causes more frequent relapses earlier in the course of the disease than other breast cancers. Researchers hav

https://www.lucc.lu.se/article/patient-specific-diagnostics-breast-cancers-are-difficult-cure - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Chronic myeloid leukaemia (CML) is a slowly progressing form of blood cancer that attacks the blood-forming cells in the bone marrow. The condition requires lifelong treatment that can cause severe side effects. Rebecca Warfvinge maps stem cells in patients in the hope of identifying predictive markers for how the pat

https://www.lucc.lu.se/article/tailored-therapy-chronic-myeloid-leukaemia - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. The European Research Council today announced the winners of its latest Consolidator Grant competition: 301 top scientists and scholars across Europe. Funding for these researchers, part of the Horizon 2020 research and innovation programme, is worth in total EUR 600 million. Filipe Pereira at Lund University in Swede

https://www.lucc.lu.se/article/prestigious-erc-grant-innovative-immunotherapy-research - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature. B cells linked to effective cancer immunotherapyCancer patients responded better to

https://www.lucc.lu.se/article/b-cells-linked-effective-cancer-immunotherapy - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. In a major study of hereditary breast cancer, a global network of researchers (including some from Lund University) has identified over 350 faults in DNA that increase an individual’s risk of developing the disease. The researchers believe that these faults can affect as many as 190 genes. Published in Nature Genetics

https://www.lucc.lu.se/article/major-study-gives-most-comprehensive-map-breast-cancer-risk - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. In their quest to find new and better methods to make cancer cells more susceptible to treatment, Karin Lindkvist and her research group at Lund University in Sweden are looking into the world of molecules, using the X-rays at the MAX IV laboratory. The researchers believe that limiting the cells' access to sugar will

https://www.lucc.lu.se/article/researchers-believe-sugar-and-obesity-can-make-cancer-cells-more-difficult-kill - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas. However, it has been a challenge to develop techniques to deliver the RNA molecules into the cells where they have an effect. Researchers at Lund University in Sweden have no

https://www.lucc.lu.se/article/rna-drugs-one-step-closer-be-being-used-cancer-treatment - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. By preventing sugar uptake, researchers succeeded in increasing the cancer cells’ sensitivity to chemotherapeutic treatment. The studies, led by researchers at Lund University in Sweden, were carried out on cancer cells in a lab environment. The results were recently published in the research journal Haematologica. Ju

https://www.lucc.lu.se/article/starved-cancer-cells-became-more-sensitive-chemotherapy - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. A new way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden. The new technology allows very sensitive, quick and cost-effective identification of cancer biomarkers. The research is published in Nature Communications Biology. Today, every third person will get cancer in the

https://www.lucc.lu.se/article/novel-biomarker-technology-cancer-diagnostics - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to specifically target lung tumors. The new study has been published in the July issue of Advanced Therapeutics. Lung tumors are ofte

https://www.lucc.lu.se/article/new-promising-treatment-uses-smart-nanoparticles-target-lung-cancer - 2026-05-01